tiprankstipranks
Trending News
More News >
Cardiff Oncology, Inc. (CRDF)
NASDAQ:CRDF
US Market

Cardiff Oncology (CRDF) Financial Statements

Compare
1,905 Followers

Cardiff Oncology Financial Overview

Cardiff Oncology's market cap is currently $189.28M. The company's EPS TTM is $-0.17; its P/E ratio is -3.52; Cardiff Oncology is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 683.00K$ 488.00K$ 386.00K$ 359.00K$ 366.00K
Gross Profit$ 683.00K$ 488.00K$ 386.00K$ 359.00K$ 366.00K
Operating Income$ -48.65M$ -45.41M$ -39.90M$ -28.86M$ -19.09M
EBITDA$ -48.25M$ -45.01M$ -39.67M$ -28.40M$ -18.84M
Net Income$ -45.43M$ -41.44M$ -38.70M$ -28.29M$ -19.31M
Balance Sheet
Cash & Short-Term Investments$ 91.75M$ 74.82M$ 105.27M$ 140.82M$ 130.98M
Total Assets$ 97.19M$ 81.64M$ 116.19M$ 149.54M$ 134.73M
Total Debt$ 1.52M$ 2.15M$ 2.71M$ 3.12M$ 869.00K
Net Debt$ -49.95M$ -19.51M$ -13.63M$ -8.82M$ -130.11M
Total Liabilities$ 14.24M$ 11.90M$ 9.85M$ 9.13M$ 6.57M
Stockholders' Equity$ 82.95M$ 69.74M$ 106.34M$ 140.42M$ 128.16M
Cash Flow
Free Cash Flow$ -37.77M$ -31.47M$ -34.71M$ -23.25M$ -16.53M
Operating Cash Flow$ -37.69M$ -30.89M$ -33.82M$ -23.04M$ -16.32M
Investing Cash Flow$ 13.73M$ 36.20M$ 38.15M$ -131.45M$ -211.00K
Financing Cash Flow$ 53.78M$ 0.00$ 75.00K$ 35.45M$ 137.31M
Currency in USD

Cardiff Oncology Earnings and Revenue History

Cardiff Oncology Debt to Assets

Cardiff Oncology Cash Flow

Cardiff Oncology Forecast EPS vs Actual EPS